In a mouse model of atherosclerosis, alpha-lipoic acid (ALA) can attenuate the progression of atherosclerosis by inhibiting the proliferation of vascular smooth muscle cells through the targeting of the Ras-MEK1/2-ERK1/2 pathway [43]. This evidence concerns the gene MAP2K1 and atherosclerosis.